ClinicalTrials.Veeva

Menu

Improving Bladder Function in SCI by Neuromodulation

University of California, Los Angeles (UCLA) logo

University of California, Los Angeles (UCLA)

Status

Enrolling

Conditions

Spinal Cord Injury

Treatments

Device: Electromagnetic Neuromodulation

Study type

Interventional

Funder types

Other

Identifiers

NCT02331979
14-000932

Details and patient eligibility

About

This trial will investigate the safety and utility of spinal cord neuromodulation to improve urinary bladder function in the context of spinal cord injury.

Full description

This trial will investigate the safety and utility of spinal cord neuromodulation to improve urinary bladder function in the context of spinal cord injury. Neuromodulation will be in the form of transcutaneous electrical stimulation and/or magnetic stimulation.

Enrollment

24 estimated patients

Sex

Male

Ages

18 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Male 18-45 years;
  2. At least 1 year post-injury;
  3. Non-progressive SCI at C2-T8 (non-conus injury);
  4. Motor Complete ASIA (A or B);
  5. Neurogenic bladder requiring clean intermittent straight catheterization;
  6. Able to attend twice weekly testing sessions for 6 months.
  7. Have intact lower extremity anatomy and able to use lower extremity for assistive standing and stepping.

Exclusion criteria

  1. History of autonomic dysreflexia;

  2. Ventilator dependency;

  3. Musculoskeletal dysfunction, unhealed fracture, pressure ulcer, active infection;

  4. Clinically significant depression or ongoing drug abuse;

  5. Received botox injection, or bladder surgery (suprapubic access, Brindley procedure, etc.); 6. Prostatic hypertrophy or bladder outlet disorder;

  6. Cardiopulmonary disease that precludes lower extremity training or rehabilitation.

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

24 participants in 3 patient groups

Stimulation of Non-Naive
Experimental group
Description:
Evaluate neuromodulation in 6 subjects with prior motor training.
Treatment:
Device: Electromagnetic Neuromodulation
Stimulation of Naive
Experimental group
Description:
Evaluate neuromodulation in 6 naive subjects.
Treatment:
Device: Electromagnetic Neuromodulation
Stimulation
Experimental group
Description:
Apply parameters discovered in Arm 1 and Arm 2 to evaluate neuromodulation in 12 naive subjects.
Treatment:
Device: Electromagnetic Neuromodulation

Trial contacts and locations

1

Loading...

Central trial contact

Daniel Lu, MD PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems